Santhera Expands Pipeline With Polyphor Cystic Fibrosis Deal
Santhera has moved into cystic fibrosis via a global licensing deal with Polyphor, expanding its rare disease pipeline.
Santhera has moved into cystic fibrosis via a global licensing deal with Polyphor, expanding its rare disease pipeline.